Pfizer COVID pill gets final approval from European Commission

Region is beefing up its defences against the coronavirus amid the rapid spread of Omicron

Last updated: January 28, 2022 | 18:16

1 MIN READ

File photo: Paxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo.

Reuters

The European Commission on Friday approved Pfizer's antiviral pill for COVID-19 a day after the region's health regulator endorsed the tablet, a move that will ensure wide availability of the promising treatment to EU member states.

Also Read: UK set to start giving Pfizer COVID-19 pill to vulnerable people

Also Read: Merck's COVID-19 pill active against Omicron in lab studies

The final go-ahead by the executive body of the European Union (EU) was tweeted by EU Health Commissioner Stella Kyriakides as the region is beefing up its defences against the coronavirus amid the rapid spread of the new Omicron variant.